Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Antiemetic Drugs Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Antiemetic Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Dopamine Antagonist
      • 1.3.3 5-HT-3 Receptor Antagonist
      • 1.3.4 NK1 Receptor Antagonist
      • 1.3.5 Cannabinoid Receptor Antagonist
    • 1.4 Market Segment by Application
      • 1.4.1 Global Antiemetic Drugs Market Share by Application (2019-2025)
      • 1.4.2 Chemotherapy
      • 1.4.3 Gastroenteritis
      • 1.4.4 Surgery
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Antiemetic Drugs Market Size
      • 2.1.1 Global Antiemetic Drugs Revenue 2014-2025
      • 2.1.2 Global Antiemetic Drugs Sales 2014-2025
    • 2.2 Antiemetic Drugs Growth Rate by Regions
      • 2.2.1 Global Antiemetic Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Antiemetic Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Antiemetic Drugs Sales by Manufacturers
      • 3.1.1 Antiemetic Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Antiemetic Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Antiemetic Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antiemetic Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Antiemetic Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Antiemetic Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Antiemetic Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Antiemetic Drugs Market
    • 3.6 Key Manufacturers Antiemetic Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Dopamine Antagonist Sales and Revenue (2014-2019)
      • 4.1.2 5-HT-3 Receptor Antagonist Sales and Revenue (2014-2019)
      • 4.1.3 NK1 Receptor Antagonist Sales and Revenue (2014-2019)
      • 4.1.4 Cannabinoid Receptor Antagonist Sales and Revenue (2014-2019)
    • 4.2 Global Antiemetic Drugs Sales Market Share by Type
    • 4.3 Global Antiemetic Drugs Revenue Market Share by Type
    • 4.4 Antiemetic Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Antiemetic Drugs Sales by Application

    6 United States

    • 6.1 United States Antiemetic Drugs Breakdown Data by Company
    • 6.2 United States Antiemetic Drugs Breakdown Data by Type
    • 6.3 United States Antiemetic Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Antiemetic Drugs Breakdown Data by Company
    • 7.2 European Union Antiemetic Drugs Breakdown Data by Type
    • 7.3 European Union Antiemetic Drugs Breakdown Data by Application

    8 China

    • 8.1 China Antiemetic Drugs Breakdown Data by Company
    • 8.2 China Antiemetic Drugs Breakdown Data by Type
    • 8.3 China Antiemetic Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Antiemetic Drugs Breakdown Data by Company
    • 9.2 Rest of World Antiemetic Drugs Breakdown Data by Type
    • 9.3 Rest of World Antiemetic Drugs Breakdown Data by Application
    • 9.4 Rest of World Antiemetic Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Antiemetic Drugs Sales by Countries
      • 9.4.2 Rest of World Antiemetic Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GlaxoSmithKline
      • 10.1.1 GlaxoSmithKline Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.1.4 Antiemetic Drugs Product Introduction
      • 10.1.5 GlaxoSmithKline Recent Development
    • 10.2 Johnson & Johnson
      • 10.2.1 Johnson & Johnson Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.2.4 Antiemetic Drugs Product Introduction
      • 10.2.5 Johnson & Johnson Recent Development
    • 10.3 Pfizer
      • 10.3.1 Pfizer Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.3.4 Antiemetic Drugs Product Introduction
      • 10.3.5 Pfizer Recent Development
    • 10.4 Sanofi
      • 10.4.1 Sanofi Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.4.4 Antiemetic Drugs Product Introduction
      • 10.4.5 Sanofi Recent Development
    • 10.5 Abbott
      • 10.5.1 Abbott Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.5.4 Antiemetic Drugs Product Introduction
      • 10.5.5 Abbott Recent Development
    • 10.6 Bristol-Myers Squibb
      • 10.6.1 Bristol-Myers Squibb Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.6.4 Antiemetic Drugs Product Introduction
      • 10.6.5 Bristol-Myers Squibb Recent Development
    • 10.7 Cipla
      • 10.7.1 Cipla Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.7.4 Antiemetic Drugs Product Introduction
      • 10.7.5 Cipla Recent Development
    • 10.8 Eisai
      • 10.8.1 Eisai Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.8.4 Antiemetic Drugs Product Introduction
      • 10.8.5 Eisai Recent Development
    • 10.9 Eli Lilly
      • 10.9.1 Eli Lilly Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.9.4 Antiemetic Drugs Product Introduction
      • 10.9.5 Eli Lilly Recent Development
    • 10.10 Glenmark
      • 10.10.1 Glenmark Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Antiemetic Drugs
      • 10.10.4 Antiemetic Drugs Product Introduction
      • 10.10.5 Glenmark Recent Development
    • 10.11 Helsinn Healthcare
    • 10.12 Heron Therapeutics
    • 10.13 IPCA Laboratories
    • 10.14 Lupin
    • 10.15 Merck
    • 10.16 Novartis
    • 10.17 RedHill
    • 10.18 Sun Pharmaceutical Industries
    • 10.19 Takeda Pharmaceutical

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Antiemetic Drugs Sales Channels
      • 11.2.2 Antiemetic Drugs Distributors
    • 11.3 Antiemetic Drugs Customers

    12 Market Forecast

    • 12.1 Global Antiemetic Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Antiemetic Drugs Sales Forecast by Type
    • 12.3 Global Antiemetic Drugs Sales Forecast by Application
    • 12.4 Antiemetic Drugs Forecast by Regions
      • 12.4.1 Global Antiemetic Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Antiemetic Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
      The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.
      In 2019, the market size of Antiemetic Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antiemetic Drugs.

      This report studies the global market size of Antiemetic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Antiemetic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GlaxoSmithKline
      Johnson & Johnson
      Pfizer
      Sanofi
      Abbott
      Bristol-Myers Squibb
      Cipla
      Eisai
      Eli Lilly
      Glenmark
      Helsinn Healthcare
      Heron Therapeutics
      IPCA Laboratories
      Lupin
      Merck
      Novartis
      RedHill
      Sun Pharmaceutical Industries
      Takeda Pharmaceutical

      Market Segment by Product Type
      Dopamine Antagonist
      5-HT-3 Receptor Antagonist
      NK1 Receptor Antagonist
      Cannabinoid Receptor Antagonist

      Market Segment by Application
      Chemotherapy
      Gastroenteritis
      Surgery

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Antiemetic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Antiemetic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Antiemetic Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now